Gene · 5324
Papers4,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Case of Metastatic Castration-Resistant Prostate Cancer With RAD54L Mutation Responding to Niraparib. | IJU Case Rep | 2025 | 41185726 | PubTator, text mining | PubMed |
| Influence of m6A regulatory factor related to immune microenvironment on the prognosis of prostate cancer. | Biomed Eng Online | 2025 | 41163172 | PubTator, text mining | PubMed |
| Genomic landscape of endometrial polyps. | Genome Med | 2025 | 41137179 | PubTator, text mining | PubMed |
| Rare case of PLAG1::RUNX1 fusion mimicking classical t(8;21): the value of optical genome mapping in acute myeloid leukemia. | Mol Cytogenet | 2025 | 41137136 | PubTator, text mining | PubMed |
| Correction to "SLIT2/ROBO1-miR-218-1-RET/PLAG1: A New Disease Pathway Involved in Hirschsprung's Disease". | J Cell Mol Med | 2025 | 41108210 | PubTator, text mining | PubMed |
| Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERα/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models. | Cell Biol Toxicol | 2025 | 41091265 | PubTator, text mining | PubMed |
| Immunoglobulin glycosylation profiling for early identification of patients with severe influenza pneumonia. | BMC Infect Dis | 2025 | 41013259 | PubTator, text mining | PubMed |
| LINE-1 266/97 and ALU 260/111 Copy Number Ratios in Circulating Cell-Free DNA in Plasma as Potential Biomarkers for the Detection of Prostate Cancer: A Pilot Case-Control Study. | Int J Mol Sci | 2025 | 41009429 | PubTator, text mining | PubMed |
| Advanced Electrochemical Sensors for Rapid and Sensitive Monitoring of Tryptophan and Tryptamine in Clinical Diagnostics. | Biosensors (Basel) | 2025 | 41002365 | PubTator, text mining | PubMed |
| Pediatric PLAG1-Rearranged Fibromyxoid Spindle Cell Tumor: An Emerging Distinct Entity or a Fibroblastic ('Non-Lipogenic') Pattern of Lipoblastoma? | Pathol Int | 2025 | 40988442 | PubTator, text mining | PubMed |
| Intelligent transdermal nanoparticles as synergizing advanced delivery systems for precision therapeutics. | Mater Today Bio | 2025 | 40917520 | PubTator, text mining | PubMed |
| Cutting-Edge Research from the 2024 Middle East Rheumatology Conference (MRC 2024) of the Gulf Cooperation Council Association of Immunology and Rheumatology (GCC-AIR). | Saudi Med J | 2025 | 40897417 | PubTator, text mining | PubMed |
| Adult Type Lipoblastoma With a Predominantly Fibroblastic Morphology and a Novel DLEU2::PLAG1 Gene Rearrangement: Two Cases of a Rare Entity. | Genes Chromosomes Cancer | 2025 | 40879377 | PubTator, text mining | PubMed |
| PLAG1-Rearranged Fibromyxoid and Lipomatous Neoplasms in Children and Adults: Separate Entities or a Morphological Spectrum? | Genes Chromosomes Cancer | 2025 | 40879223 | PubTator, text mining | PubMed |
| Diagnostic Pitfalls in Fine Needle Aspiration of Pleomorphic Adenoma: Degenerative Changes in Myoepithelial Cells as Malignant and PLAG1 False Negativity. | Diagn Cytopathol | 2025 | 40879148 | PubTator, text mining | PubMed |
| Uterine Myxoid Mesenchymal Tumor With a Novel SS18::VEZF1 Gene Fusion, Lacking Worrisome Histological Features. | Genes Chromosomes Cancer | 2025 | 40878061 | PubTator, text mining | PubMed |
| Potential role of DKK3 and WIF1 in prostate cancer: bioinformatics and clinical analysis. | Discov Oncol | 2025 | 40864208 | PubTator, text mining | PubMed |
| Dynamic Susceptibility Contrast Magnetic Resonance Imaging with Carbon-Encapsulated Iron Nanoparticles Navigated to Integrin Alfa V Beta 3 Receptors in Rat Glioma. | Nanomaterials (Basel) | 2025 | 40863857 | PubTator, text mining | PubMed |
| Single-Center Cross-Sectional Analysis of Patients with RA, SpA, and PsA: Data from the Prescription Database. | J Pers Med | 2025 | 40863428 | PubTator, text mining | PubMed |
| BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities. | Eur J Med Res | 2025 | 40859340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5324/papers?page=7